PlainPharmaWatch

CMS Open Payments · Tool

Braintree Laboratories, Inc. vs Kite Pharma, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Braintree Laboratories, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,132, versus 462 for the other company. Its single largest recorded recipient represents 0.3% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Braintree Laboratories, Inc.
HHI 2,132 · top recipient 0.3%
Ranked #728 of 1,838 companies by HHI
Kite Pharma, Inc.
HHI 462 · top recipient 0.2%
Ranked #1,317 of 1,838 companies by HHI

Payment Overview

Total Payments
$33.9M
% of Industry
0.2%
Transactions
8,836
Avg per Transaction
$3.8K
Recipients
5,369
Avg per Recipient
$6.3K
Payment Types
6
Top Payment Type
Royalty or License
Company B

Kite Pharma, Inc.

Total Payments
$34.1M
% of Industry
0.2%
Transactions
4,309
Avg per Transaction
$7.9K
Recipients
2,852
Avg per Recipient
$12.0K
Payment Types
8
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Braintree Laboratories, Inc. vs Kite Pharma, Inc. - total reported payments in CMS Open Payments PY2024

Kite Pharma, Inc.$34.1MBraintree Laboratories, Inc.$33.9M

Payment Types Breakdown

Braintree Laboratories, Inc.

Royalty or License $382.1K

1.1%

Consulting Fee $144.9K

0.4%

Food and Beverage $106.6K

0.3%

Gift $12.9K

0.0%

Grant $5.5K

0.0%

Education $80.85

0.0%

Kite Pharma, Inc.

Compensation for Services Other Than Consulting $523.1K

1.5%

Consulting Fee $297.5K

0.9%

Royalty or License $200.0K

0.6%

Space Rental or Facility Fees $135.5K

0.4%

Food and Beverage $102.5K

0.3%

Grant $37.5K

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Braintree Laboratories, Inc.

  1. 1

    JOHN FORDTRAN

    $224,157.00 · 8 txns

  2. 2

    GLENN DAVIS

    $157,911.49 · 4 txns

  3. 3

    JACK DIPALMA

    $124,029.21 · 12 txns

  4. 4

    FRANCIS FARRAYE

    $5,000.00 · 1 txns

  5. 5

    DANIEL JOHN PAMBIANCO

    $4,039.33 · 2 txns

Kite Pharma, Inc.

  1. 1

    Hospital Of The Univ Of Penna

    $254,315.20 · 12 txns

  2. 2

    MARCO DAVILA

    $47,463.86 · 18 txns

  3. 3

    LEONARD ALSFELD

    $40,421.09 · 26 txns

  4. 4

    RAGHUVEER RANGANATHAN

    $29,312.00 · 13 txns

  5. 5

    RUSHANG PATEL

    $28,028.15 · 28 txns

Summary Comparison

Metric Braintree Laboratories, Inc. Kite Pharma, Inc.
Total Payments $33.9M $34.1M
% of Industry Total 0.2% 0.2%
Transaction Count 8,836 4,309
Avg per Transaction $3.8K $7.9K
Recipient Count 5,369 2,852
Avg per Recipient $6.3K $12.0K
Payment Type Count 6 8
Top Payment Type Royalty or License Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.